EUVIMEDEUVIMED entdecken
Open Access

Salmonella Typhimurium alters galactitol metabolism under ciprofloxacin treatment to balance resistance and virulence

Qiwei Chen iD, Yongfeng Yu, Yongchang Xu iD, Heng Quan, Donghui Liu, Caiyu Li, Mengyao Liu, Xiaowei Gong iD

Journal of Bacteriology · 2024

DOI: 10.1128/jb.00178-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, 2024. Verfasst von Qiwei Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, College of Animal Medicine and Biosafety, Lanzhou University, Lanzhou Veterinary Rese…. Hauptthemen laut MEDLINE: Ciprofloxacin, Salmonella typhimurium, Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ciprofloxacin-resistant Salmonella Typhimurium ( S. Typhimurium) causes a significant health burden worldwide. A wealth of studies has been published on the contributions of different mechanisms to ciprofloxacin resistance in Salmonella spp. But we still lack a deep understanding of the physiological responses and genetic changes that underlie ciprofloxacin exposure. This study aims to know how phenotypic and genotypic characteristics are impacted by ciprofloxacin exposure, from ciprofloxacin-susceptible to ciprofloxacin-resistant strains in vitro . Here, we investigated the multistep evolution of resistance in replicate populations of S. Typhimurium during 24 days of continuously increasing ciprofloxacin exposure and assessed how ciprofloxacin impacts physiology and genetics. Numerous studies have demonstrated that RamA is a global transcriptional regulator that prominently perturbs the transcriptional landscape of S. Typhimurium, resulting in a ciprofloxacin-resistant phenotype appearing first; the quinolone resistance-determining region mutation site can only be detected later. Comparing the microbial physiological changes and RNA sequencing (RNA-Seq) results of ancestral and selectable mutant strains, the selectable mutant strains had some fitness costs, such as decreased virulence, an increase of biofilm-forming ability, a change of “collateral” sensitivity to other drugs, and inability to utilize galactitol. Importantly, in the ciprofloxacin induced, RamA directly binds and activates the gatR gene responsible for the utilization of galactitol, but RamA deletion strains could not activate gatR . The elevated levels of RamA, which inhibit the galactitol metabolic pathway through the activation of gatR , can lead to a reduction in the growth rate, adhesion, and colonization resistance of S . Typhimurium. This finding is supported by studies conducted in M9 medium as well as in vivo infection models. IMPORTANCE Treatment of antibiotic resistance can significantly benefit from a deeper understanding of the interactions between drugs and genetics. The physiological responses and genetic mechanisms in antibiotic-exposed bacteria are not well understood. Traditional resistance studies, often retrospective, fail to capture the entire resistance development process and typically exhibit unpredictable dynamics. To explore how clinical isolates of S. Typhimurium respond to ciprofloxacin, we analyzed their adaptive responses. We found that S. Typhimurium RamA-mediated regulation disrupts microbial metabolism under ciprofloxacin exposure, affecting genes in the galactitol metabolic pathways. This disruption facilitates adaptive responses to drug therapy and enhances the efficiency of intracellular survival. A more comprehensive and integrated understanding of these physiological and genetic changes is crucial for improving treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CiprofloxacinSalmonella typhimuriumDrug Resistance, BacterialAnti-Bacterial AgentsGene Expression Regulation, BacterialVirulenceBacterial ProteinsAnimalsMiceBiofilmsMicrobial Sensitivity TestsMutation

Stichwörter der Autor:innen

RamASalmonella Typhimuriumciprofloxacin resistanceexperimental evolutiongalactitol utilization

Substanzen

CiprofloxacinAnti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, College of Animal Medicine and Biosafety, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gan…
  • Department of Immunology and Pathogen Biology, Key Laboratory of Aging and Cancer Biology of Zhejiang Province, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.

ORCID-Profile: Qiwei Chen, Yongchang Xu, Xiaowei Gong

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Chen, Q., Yu, Y., Xu, Y., Quan, H., Liu, D., Li, C., Liu, M., & Gong, X. (2024). Salmonella Typhimurium alters galactitol metabolism under ciprofloxacin treatment to balance resistance and virulence. Journal of Bacteriology. https://doi.org/10.1128/jb.00178-24

Vancouver

Chen Q, Yu Y, Xu Y, Quan H, Liu D, Li C, et al. Salmonella Typhimurium alters galactitol metabolism under ciprofloxacin treatment to balance resistance and virulence. Journal of Bacteriology. 2024. doi:10.1128/jb.00178-24

BibTeX
@article{Chen2024,
  author = {Chen, Qiwei and Yu, Yongfeng and Xu, Yongchang and Quan, Heng and Liu, Donghui and Li, Caiyu and Liu, Mengyao and Gong, Xiaowei},
  title = {Salmonella Typhimurium alters galactitol metabolism under ciprofloxacin treatment to balance resistance and virulence},
  journal = {Journal of Bacteriology},
  year = {2024},
  doi = {10.1128/jb.00178-24}
}
Kostenlos starten →